Clinical Trial Update: Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine hydrochloride with radiation therapy for borderline resectable pancreatic cancer (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Stage Iia Pancreatic Cancer
• Stage Iib Pancreatic Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Pancreatic Adenocarcinoma, Stage IIA Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-12-05